Details of the Drug Reposition

General Information of This Drug (ID: DMOUEY7)

Drug Name
Mesenchymal stem cells   DMOUEY7
Synonyms MSCs
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Epidermolysis bullosa DISVOTZQ EC3Z Approved [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Phase 2 [2]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (FDA ORPHAN DRUG) 427014
2 ClinicalTrials.gov (NCT04288102) Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19). U.S. National Institutes of Health.